Test-Retest Reliability of Multi-Metabolite Edited MRS at 3T Using PRESS and sLASER
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
PURPOSE: Spectral editing is the most common MRS approach for noninvasive in vivo measurement of low-concentration, strongly overlapped metabolites in the brain, such as γ-aminobutyric acid (GABA) and glutathione (GSH). Multi-metabolite editing methods, such as HERMES and HERCULES, enable the editing of multiple J-coupled metabolites in a single acquisition without increasing the total scan time. Yet little is known regarding the reliability of these methods. This study assessed the test-retest reliability of HERMES and HERCULES, where volume localization was achieved using both PRESS and sLASER. METHODS: Sixteen healthy adult volunteers were scanned twice in two separate sessions. Single-voxel edited MRS data were acquired in the medial parietal lobe using the following sequences: (1) HERMES-PRESS; (2) HERMES-sLASER; (3) HERCULES-PRESS; (4) HERCULES-sLASER. Spectra were processed and metabolites were quantified relative to tCr. Data quality metrics and reliability statistics were estimated for all four acquisitions. RESULTS: HERMES-sLASER produced lower within-subject coefficients of variation (CVws) for GABA + co-edited macromolecules (GABA+), GSH, glutamine (Gln), myo-inositol (mI), NAA, and total Cho (tCho), suggesting improved reliability compared to HERMES-PRESS. HERCULES-sLASER produced better reliability than HERCULES-PRESS for GABA+, GSH, aspartate, Gln, lactate, mI, NAA, and tCho with lower CVws. N-acetylaspartylglutamate (NAAG) showed higher CVws for HERCULES-sLASER, and Glu showed higher CVws for HERMES-sLASER and HERCULES-sLASER. Overall, these findings suggest that sLASER yields lower within-subject variability than PRESS for several metabolites for both HERMES and HERCULES, supporting improved measurement reliability. CONCLUSION: sLASER yielded better test-retest reliability than PRESS for most metabolites than for multi-metabolite edited MRS.